Stay updated on HD Nusinersen After Risdiplam in SMA Clinical Trial
Sign up to get notified when there's something new on the HD Nusinersen After Risdiplam in SMA Clinical Trial page.

Latest updates to the HD Nusinersen After Risdiplam in SMA Clinical Trial page
- CheckyesterdayChange DetectedThe Biogen-sponsored ASCEND study record is displayed, showing that the SMA trial is active but not recruiting, has no results posted, and has estimated primary and study completion dates of 2027-09-24.SummaryDifference7%

- Check8 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0; the page still displays a 403 error.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedA sitewide NIH notice about using “Super Intelligence” in place of “Artificial Intelligence” was added, and the site revision changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check36 days agoChange DetectedThe site revision shown in the footer changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check50 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study results view with an error page. Access to the study details and results is no longer available from this URL due to the access issue.SummaryDifference6%

- Check57 days agoChange DetectedThe page shows a new Revision tag v3.7.0, replacing v3.6.6, indicating a software update to the interface rather than changes to study results.SummaryDifference0.1%

Stay in the know with updates to HD Nusinersen After Risdiplam in SMA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HD Nusinersen After Risdiplam in SMA Clinical Trial page.